コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ut any false-positive results (100% positive predictive value).
2 c biliary disease-again showed the strongest predictive value.
3 of the 'novel' predictors added significant predictive value.
4 about unique histological features and their predictive value.
5 nt characteristics was of limited additional predictive value.
6 ard for calculating sensitivity and positive predictive value.
7 nical outcome scores to determine a possible predictive value.
8 SD, nsVT, and obstruction showed significant predictive values.
9 ation, or pulmonary hemorrhage did not alter predictive values.
11 specificity 88% (95% CI, 87%-89%), positive predictive value 10% (95% CI, 9%-12%), and negative pred
12 ivity (100% versus 70%, P<0.05) and negative predictive value (100% versus 89%, P<0.05) than QRS dura
14 a, had a higher sensitivity (100%), negative predictive value (100%), and accuracy (66%) for malignan
16 p16 had lower sensitivity (83%) and positive predictive value (40%) but high specificity (94%) and ne
20 n = 95), specificity(82% vs. 62%), positive predictive value(66% vs. 50%) and area under curve (0.81
21 ostic sensitivity, specificity, and negative predictive values (70% to 100%) but low positive predict
22 .5%, respectively) and positive and negative predictive values (74.7% and 78.5%, respectively) was ac
23 % sensitivity, 51% specificity, 44% positive predictive value, 80% negative predictive value, and lik
24 -ERK expression showed an increased positive predictive value (81.8% vs 75.9%) and an increased speci
26 ing out sc-TCMR (specificity = 70%, negative predictive value = 92.5%), but could not predict sc-ABMR
27 predicting sc-AR (specificity, 98%; positive predictive value 93%) (all sc-ABMR and 58% sc-TCMR showe
28 XCL8 in healthy individuals found a negative predictive value 93.5%, given the population prevalence
29 m(2) and strain >23.4% yielded high negative predictive value (93% and 98%, respectively) for new-ons
30 tivity = 100%, specificity = 97.4%, positive predictive value = 93.3%, negative predictive value = 10
31 y treatment success both had a high positive predictive value (94.3%-100.0%) for late clinical cure,
32 89% vs. 78%specificity, 73% vs. 57%positive predictive value, 95% vs. 94%negative predictive value,
35 ing 18 index and two 30-day events (negative predictive value, 97.9%; 95% confidence interval, 96.9-9
36 s low risk for the primary outcome (negative predictive value, 98.4%; 95% confidence interval [CI], 9
38 sing 2 index and two 30-day events (negative predictive value, 99.5%; 95% confidence interval, 99.0-9
39 (P<0.001) with similar performance (negative predictive value, 99.7%; 95% CI, 99.4%-99.9%; sensitivit
40 with specificity, sensitivity, and positive predictive value all >99%, whereas other linkages result
41 CCL17 and CCL26 expression had 100% positive predictive value and 87% negative predictive value for a
47 sitive predictive value, 95% vs. 94%negative predictive value, and 0.87 vs. 0.82 area under curve, al
48 ificity, negative predictive value, positive predictive value, and accuracy were 95.2%, 75%, 96.4%, 6
50 44% positive predictive value, 80% negative predictive value, and likelihood ratio 1.54 to predict s
54 nstrating sensitivity, specificity, positive predictive value, and negative predictive value of 85.3%
55 es with a sensitivity, specificity, positive predictive value, and negative predictive value of 96.0%
56 was used to determine positive and negative predictive values, and a full logistic regression model
57 ze their development, positive- and negative-predictive values, and ability to predict response to tr
58 e and downgrade rates, positive and negative predictive values, and positive and negative likelihood
60 in image contrast, sensitivity, or positive predictive values between the 2 (68)Ga-OPS202 peptide do
61 E/e' data improves sensitivity and negative predictive value but compromises specificity, suggesting
62 F to CHA2DS2-VASc statistically improved its predictive value, but c-indexes were not significantly d
64 approach had a significantly higher positive predictive value compared to minimum inhibitory concentr
67 tients in each group), NT-proBNP had similar predictive value for adverse cardiovascular outcomes, ir
68 % positive predictive value and 87% negative predictive value for airway mucosal CCL26-high status.
70 lded a success rate of 92%, and the negative predictive value for both the influenza A and B assay wa
71 gh-risk patients is essential, as these have predictive value for conversion to psychosis and likelih
72 is to be realized and biomarkers are to have predictive value for determining the magnitude of risk f
74 ach other, were of only moderate independent predictive value for distant recurrence, but the status
75 ted to identifying signaling phenotypes with predictive value for early diagnosis, prognosis, or rela
77 motor reaction had greater than 70% positive predictive value for good outcome; reactivity (80.4%; 95
78 teria also improved specificity and positive predictive value for HCC (R1, two fewer false-positive f
79 5V pathway improved specificity and positive predictive value for HCC to 83.3% and 92.9%, respectivel
81 losis infection (LTBI) are limited by a poor predictive value for identifying people at the highest r
83 ATRIA, ORBIT and HEMORR2HAGES improved their predictive value for major bleeding leading to improved
84 ation between the duration of monitoring and predictive value for mortality (R = 0.78; p < 0.001).
87 ity, positive predictive value, and negative predictive value for NLP algorithm in predicting asthma
88 ity, positive predictive value, and negative predictive value for OC/FTC detection within 1 year were
89 New R ratio Hy's law had a higher positive predictive value for overall fatality (14% versus 10%) a
90 Early warning scores are known to have good predictive value for patient deterioration and have been
91 ity, positive predictive value, and negative predictive value for PLC injuries were 55% (11 of 20), 9
92 sease had 88% specificity and a 92% positive predictive value for predicting the presence of a BRAF m
95 oreover, a number of imaging features showed predictive value for specific pathways; for example, int
99 rmore, theta oscillatory activity may have a predictive value for the clinical benefit after chronic
103 gorithm yielded an average of 95.8% positive predictive values for both cases and control subjects.
105 vity, specificity, and positive and negative predictive values for malignant tumors of the conjunctiv
106 and hindbrain had high negative and positive predictive values for survival for less than a year.
107 collection of 200 clinical Acinetobacter sp. Predictive values for susceptibility and resistance were
109 vity, specificity, and positive and negative predictive values for WGS in predicting AMR were 0.87, 0
111 racking of infiltrating macrophages may have predictive value in determining whether transplanted ste
113 justed alpha = .0125), with highest positive predictive value in phase 1 (64.0%) and highest negative
118 0.97 [745 of 766]) were higher than positive predictive values (men, 0.01 [88 of 582]; women, 0.16 [1
121 The primary outcome measure was the negative predictive value (NPV) of FDG-PET/CT scans and other sup
122 ositive predictive value (PPV), and negative predictive value (NPV) of RDTs were 51.7%, 94.1%, 67.3%,
123 positive predictive value (PPV) and negative predictive value (NPV) of ST for anaphylaxis related to
125 sitive predictive values (PPV), and negative predictive values (NPV) were 92.7%, 100%, 100%, and 94.3
127 equired neurosurgical intervention (negative predictive value [NPV], 100.0% [95% CI: 99.9%-100.0%]).
128 sitive predictive values (PPVs) and negative predictive values (NPVs) by comparing agreement in class
130 ficity, positive predictive values, negative predictive values (NPVs), and accuracy were calculated f
131 urther studies are warranted to evaluate the predictive value of (89)Zr-bevacizumab PET for everolimu
132 UC of 0.88 (95% CI 0.79-0.94) and a negative predictive value of 0.92 (95% 0.88-0.95) at the predefin
134 sensitivity of 100.0% and 63.6% and negative predictive value of 100.0% and 66.6%, respectively.
136 sensitivity, specificity, PPV, and negative predictive value of 47.6%, 93.9%, 55.6%, and 91.9% for c
137 % sensitivity, 60.8% specificity, a positive predictive value of 5.7%, and a negative predictive valu
138 ositive predictive value (PPV), and negative predictive value of 54.8%, 97.7%, 79.3%, and 93.1% for c
139 This study sought to compare the incremental predictive value of 7 different frailty scales to predic
140 ded a Dice coefficient of 75.86%, a positive predictive value of 71.62% and a negative predictive val
141 pecificity of 93.1% (364 of 391), a positive predictive value of 74.8% (80 of 107), and a negative pr
142 r was below the threshold, it had a positive predictive value of 75%, and when both parameters exceed
144 511) and B (n = 127) demonstrated a positive predictive value of 78.4% for "clinical AERD," which ros
146 minate Quantiferon-CMV result had a positive predictive value of 83% and a negative predictive value
148 0), accuracy of 92.7% (227 of 245), positive predictive value of 84.3% (70 of 83), and negative predi
149 ity, positive predictive value, and negative predictive value of 85.3%, 93.9%, 27.4%, and 99.6%, resp
151 (58.4%; 95% CI, 57.7-59.1), with a positive predictive value of 89.6% (95% CI, 89.1-90.1) and negati
153 or M65, a cutoff of 2000 IU/L had a positive predictive value of 91%, whereas a cutoff of 641 IU/L ha
158 y of 88.9% and 63.9% (P = .013) and negative predictive value of 93.1% and 80.9% (P = .045), respecti
160 ficity of 99.3%, accuracy of 93.9%, positive predictive value of 94.1%, and negative predictive value
162 11), accuracy of 91.2% (31 of 34), positive predictive value of 95.5% (21 of 22), and a negative pre
163 ity, positive predictive value, and negative predictive value of 96.0% (95% confidence interval [CI],
164 ve predictive value of 71.62% and a negative predictive value of 96.77% in terms of pixel-by-pixel ev
165 tive value of 84.3% (70 of 83), and negative predictive value of 96.9% (157 of 162) for the detection
166 itive predictive value of 83% and a negative predictive value of 98% for identifying participants at
167 ive value 10% (95% CI, 9%-12%), and negative predictive value of 99% (95% CI, 98%-100%) in the popula
168 ral Performance Category 4-5 with a positive predictive value of 99%, false positive rate of 0.5%, an
173 days and 7 (0.1%) at 1 year, with a negative predictive value of 99.9% (95% CI, 99.7%-99.9%) for card
175 and meta-analysis of studies evaluating the predictive value of acute MRI lesion patterns for discri
177 Some progression algorithms added to the predictive value of baseline CT and risk assessment in t
179 cluded cancer detection rate (CDR), positive predictive value of biopsy recommendation (PPV2), sensit
180 tive predictive value of recall and positive predictive value of biopsy were lowest in women who had
181 ositive predictive value of recall, positive predictive value of biopsy, cancer detection rate, sensi
182 ary outcome was a comparison of the negative predictive value of both pathways for index type 1 myoca
185 bust between cohorts and added little to the predictive value of clinical covariates for exacerbation
187 (at least 1 of the 3 features), the positive predictive value of confocal microscopy was 87.5% and th
189 e considered the reference standard, and the predictive value of diameter and volume changes was anal
196 omatic C. difficile carriage, the diagnostic predictive value of NAATs is limited when used in patien
197 vision than refractory eyes (P < 0.001), the predictive value of OCT findings did not differ accordin
198 between cases and controls and examined the predictive value of plasma GPBB for 90-day functional ou
204 Given the high sensitivity and negative predictive value of results obtained, BacterioScan 216Dx
205 was to measure the sensitivity and negative predictive value of sentinel-lymph-node mapping compared
207 reactions to botulinum antitoxin and (2) the predictive value of skin testing (ST) before botulinum a
208 rate of anaphylaxis, fatal outcomes, modest predictive value of ST, resource requirements for ST, an
209 e responses to particular stimuli beyond the predictive value of stimulus intensity or self-reports o
212 FDG PET analysis was conducted to assess the predictive value of the metabolic response to BR compare
221 The sensitivity, specificity, and positive predictive value of ultrasound in diagnosing dengue feve
224 for prediction of preeclampsia, and positive predictive values of 4% in the largest, most applicable
225 cificity of 71.4%, and positive and negative predictive values of 45.1% and 98.8%, respectively.
227 itivity, specificity, positive, and negative predictive values of 84%, 80%, 64%, and 92%, respectivel
228 pecificity of 99%, and positive and negative predictive values of 89% and 100% for detecting active t
229 nd ADC change measurements achieved negative predictive values of 96% (44 of 46) to 100% (39 of 39).
230 v2.0 displayed overall positive and negative predictive values of 99.7% (CI95: 95.4-98.9) and 97.5% (
232 2 years as outcome measures, we assessed the predictive values of baseline clinical variables and sep
233 Because of the low prevalence, negative predictive values of CLQ cutoff values (men, 0.99 [573 o
234 er, the very good negative and good positive predictive values of iPET support its use in daily pract
239 ies and calculated the positive and negative predictive values of the Lipsker and of the Strasbourg c
240 Despite the increased risk, the positive predictive values of this symptom cluster were low, rang
241 (ie, one with high sensitivity and negative predictive value) of the MPD diameter on CT or MRI as a
242 95% CI 0.56-0.84), but had also significant predictive value on its own (AUC=0.65, 95% CI 0.52-0.79)
243 Moreover, such spontaneous dynamics show predictive value over individual cognitive profile and c
245 al score, sensitivity, specificity, negative predictive value, positive predictive value, and accurac
246 sitivity, specificity, positive and negative predictive values, positive and negative likelihood rati
247 ivity, specificity and positive and negative predictive value (PPV and NPV) for the two Arabic CAM-IC
250 RNA-Seq data, including the highest Positive Predictive Value (PPV) compared to the current state-of-
254 of 85.86%, specificity of 100%, and positive predictive value (PPV) of 100% for detecting causes of c
255 rate, 12.6% (95% CI: 12.5%, 12.7%); positive predictive value (PPV) of a biopsy recommendation (PPV2)
258 clinical history of reactivity, 95% positive predictive value (PPV) or challenge, corrected for ances
259 PCR, the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (N
260 onstrated sensitivity, specificity, positive predictive value (PPV), and negative predictive value of
262 accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV),
263 aimed to validate the positive and negative predictive values (PPV and NPV) of these diagnostic proc
265 , the sensitivities, specificities, positive predictive values (PPV), and negative predictive values
266 cancer consistently resulted in low positive predictive values (PPVs) and false-positive rates, with
268 umber of positive test results, and positive predictive values (PPVs) for advanced neoplasia were det
272 in part to a lack of robust biomarkers with predictive value, some optimism has come from the identi
274 PLR < 13% had 100% specificity and positive predictive value to predict poor recovery (0% false-posi
275 ochemotherapy, iPET has a very good negative predictive value, utilizing both visual (qualitative) an
279 cificity was 85% (95% CI, 75%-92%), positive predictive value was 72% (95% CI, 61%-90%), and negative
287 ders' positive predictive value and negative predictive value were broadly consistent with each other
288 ositive predictive value (PPV), and negative predictive value were calculated for both imaging modali
291 99.23%, respectively; positive and negative predictive values were 92.01% and 99.91%, respectively.
292 3.5% (P = 0.001), respectively; and positive predictive values were 94.2% and 89.3%, respectively (P
293 ates, sensitivity, specificity, and positive predictive values were calculated for both mammography a
294 ions were 22% and 2%, respectively; negative predictive values were especially low for 10- to 12-year
297 ase and from AQP4 antibody disease with high predictive values, while MOG antibody disease could not
298 with DBT-FFDM (61.3%, P = .01), and positive predictive values with DBT-s2D mammography (40.8%) were
299 ncreased their ability of discrimination and predictive value, with significant improvements in recla
300 d practice improved recall rate and positive predictive values without loss of cancer detection rate
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。